Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“The levels of leukotriene B4 , thromboxane A2, and prostaglandin I2 were significantly lower in patients receiving EPA than in those not receiving it (all P < 0.01).”
“Pretreatment of PMNs with either EPA or DHA reduced the receptor expression for both FMLP and LTB4.”
“The stimulated [Ca2+]i by either FMLP or LTB4 was suppressed in a high Ca2+ environment after pretreatment with either EPA or DHA but not with OA or LA.”
JPEN. Journal of parenteral and enteral nutrition • 2004 | View Paper
“Added EPA (10 μ molL‐1) also suppressed 4‐series 5‐LOP and significantly reduced leukotriene B4 concentration by 48% from 39.9 ±3.2 to 20.6 ± 11.4 pmol L‐1 again with a concomittant increase of inactive 5‐series metabolites.”
European journal of clinical investigation • 1995 | View Paper
“It has been demonstrated that both auranofin and eicosapentaenoic acid (EPA) have anti-inflammatory properties and both inhibit neutrophil leukotriene B4 (LTB4) synthesis.”
“The … EPA on monocyte function in …: (1) suppression of LTB4 synthesis concomitantly with that of the other 5-lipoxygenase pathway products and decreased [3H]-arachidonic acid release, (2) suppression of …, and (3) delayed kinetics of inhibition of PAF generation and AA metabolism relative to that of cellular lipid alteration.”
World review of nutrition and dietetics • 1991 | View Paper
“ EPA decreased the production of leukotriene B4 (LTB4) and increased the formation of leukotriene B5 (LTB5) and 5-hydroxyeicosapentaenoic acid significantly in A23187-stimulated neutrophils.”
“ EPA and DHA, when released, inhibit cyclooxygenase and lipoxygenase and reduce eicosanoid synthesis, particularly thromboxane (TXA2) and leukotriene B4 (LTB4), by platelets and macrophages.”
The American journal of clinical nutrition • 1990 | View Paper
“The dietary introduction of n-3 fatty acids, such as EPA , may reduce the epidermopoiesis and neutrophil migration evoked by LTB4 through decreases in generation of LTB4 and the capacity of LTB5 to inhibit the effects of LTB4.”